Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

2(50%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

25%

Ph phase_1

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Phase 1Safety & dosage

1(50.0%)

N/ANon-phased studies

1(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Detailed Status

Completed2

Recruiting1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (50.0%)

N/A1 (50.0%)

Trials by Status

recruiting125%

active_not_recruiting125%

completed250%

Recent Activity

2 active trials

Showing 4 of 4

active_not_recruitingnot_applicable

The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment Response

NCT06050395

recruiting

Young Adult Infusion Space Experience Satisfaction Survey

NCT05720546

completedphase_1

Addressing Unmet Basic Needs to Improve Adherence Among Women With an Abnormal Pap

NCT03317470

completed

Morbidity and Mortality Follow Up for the Scleroderma Lung Study

NCT01762449

Clinical Trials (4)

Showing 4 of 4 trials

NCT06050395Not Applicable

The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment Response

Active Not Recruiting

NCT05720546

Young Adult Infusion Space Experience Satisfaction Survey

Recruiting

NCT03317470Phase 1

Addressing Unmet Basic Needs to Improve Adherence Among Women With an Abnormal Pap

Completed

NCT01762449

Morbidity and Mortality Follow Up for the Scleroderma Lung Study

Completed

All 4 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 4